QBRELIS

Generic: LISINOPRIL

Manufacturer: Azurity Pharmaceuticals, Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]HMG-CoA Reductase Inhibitor [EPC]Corticosteroid [EPC]Proton Pump Inhibitor [EPC]
288,349
Total Reports
75,960
Serious Reports
23,422
Death Reports
30
Reported Reactions
Death Report Ratio: High (8.12%)

Patient Demographics

Male
130,818
Female
140,448

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for QBRELIS.

# Reaction Reports % of Total
1 FATIGUE 18,731
6.4%
2 NAUSEA 17,343
5.9%
3 DRUG INEFFECTIVE 16,677
5.7%
4 DIARRHOEA 16,287
5.5%
5 DYSPNOEA 13,112
4.5%
6 PAIN 12,810
4.4%
7 DIZZINESS 12,673
4.3%
8 HEADACHE 12,079
4.1%
9 ASTHENIA 10,259
3.5%
10 VOMITING 10,128
3.4%
11 OFF LABEL USE 10,115
3.4%
12 ACUTE KIDNEY INJURY 9,170
3.1%
13 CHRONIC KIDNEY DISEASE 8,984
3.1%
14 ARTHRALGIA 8,980
3.1%
15 FALL 8,540
2.9%
16 RASH 8,035
2.7%
17 HYPERTENSION 7,988
2.7%
18 DEATH 7,928
2.7%
19 MALAISE 7,883
2.7%
20 WEIGHT DECREASED 7,654
2.6%
21 COUGH 7,653
2.6%
22 PRURITUS 7,440
2.5%
23 PAIN IN EXTREMITY 7,401
2.5%
24 RENAL FAILURE 7,264
2.5%
25 PNEUMONIA 6,831
2.3%
26 ANXIETY 6,763
2.3%
27 DECREASED APPETITE 6,496
2.2%
28 ANGIOEDEMA 6,485
2.2%
29 INSOMNIA 6,283
2.1%
30 HYPOTENSION 6,214
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.